antiquity
02-25-2002, 11:11 AM
Global Innovative Systems, Inc. Announces Filing of the 8K Reporting The Acquisition of Energy Medicine Developments Corp., and the Addition of The ENERMED Founders to the Board of Directors
Global Innovative Systems, Inc. (GBIS)
Las Vegas, Nevada USA
LAS VEGAS, Feb. 25 /PRNewswire-FirstCall/ -- Global Innovative Systems, Inc (OTC Bulletin Board: GBIS) -- The Company is pleased to announce that it has filed the 8K reflecting the acquisition of Energy Medicine Developments Corp. Energy Medicine Developments owns the intellectual property and technology of the pulsed electromagnetic ENERMED device, the supporting bioelectromagnetic analysis equipment, and the worldwide rights to manufacture and market this equipment.
The Enermed Therapy is currently licensed by Health Canada to provide non- invasive symptomatic relief to people with multiple sclerosis and/or migraine headaches. The effectiveness of the Enermed Therapy has been evaluated through controlled clinical trials. Additionally a company survey mailed to Enermed patients one to fifteen months after they received their individually programmed Enermed devices indicated that the large majority of people using the device experienced improvement in their condition.
At this time the Company is also pleased to announce that that the two founding principals of Energy Medicine Developments doing business as ENERMED have agreed to join its Board of Directors. After incorporating Energy Medicine Developments in 1994 the principals have overseen the opening of the initial treatment centre in Vancouver, British Columbia in 1995 and a second treatment centre in Toronto, Ontario in 1997. Both have been active in the Company's growth and will continue to oversee the ongoing growth of the business in North America and internationally.
Robert Michael Fletcher, CGA; educated in Great Britain, he worked in England and on contract in Bermuda, before he emigrated to Canada in 1972. He was employed as Senior Vice President Canada by a US based, multi national financial organization which was responsible for providing corporate finance and consulting advice. He incorporated his own specialized corporate financial service company in 1983. He became a consultant to the health care industry in the early 1990's and together with Fraser Wilson Lawrie was responsible for the incorporation of Energy Medicine Developments in 1994. He has been actively involved with the Company since its incorporation. He received his Certified General Accountant designation in 1985.
Fraser Wilson Lawrie, M.S.; educated in Scotland, he emigrated to Canada in 1979 and pursued a career in the pharmaceutical industry. Whilst working as a consultant to the health care industry he became interested in pulsed electromagnetic therapy in the early 1990's culminating in the establishment of Energy Medicine Developments in 1994. He has been actively involved with the Company since its incorporation. He has a Masters Degree in Health Science.
The Company is also pleased to confirm Energy Medicine Developments Medical Advisory Board chaired by Dr. Martha Lappin and including Robert Fabiny, MD, Ph.D.; Eric Kramer, MD; and Todd Richards, Ph.D. as announced December 4th, 2001.
For more information on the Enermed Therapy for the symptomatic relief of MS and Migraine headaches visit the Company's website at www.enermed.com (http://www.enermed.com) or, to schedule an appointment for the Enermed Therapy call 1-866-ENERMED. For information on Investor Relations, contact Yorkville Capital Partners, LLC at (212) 585-2300.
Certain of these statements contained in the press release may be deemed forward-looking statements. Such statements, and other matters addressed in this press release, involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from these statements and matters are the risks and other factors detailed, from time to time, in the Company's reports with Securities and Exchange Commissions, including, but not limited to, the Company's Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q.
Global Innovative Systems, Inc. (GBIS)
Las Vegas, Nevada USA
LAS VEGAS, Feb. 25 /PRNewswire-FirstCall/ -- Global Innovative Systems, Inc (OTC Bulletin Board: GBIS) -- The Company is pleased to announce that it has filed the 8K reflecting the acquisition of Energy Medicine Developments Corp. Energy Medicine Developments owns the intellectual property and technology of the pulsed electromagnetic ENERMED device, the supporting bioelectromagnetic analysis equipment, and the worldwide rights to manufacture and market this equipment.
The Enermed Therapy is currently licensed by Health Canada to provide non- invasive symptomatic relief to people with multiple sclerosis and/or migraine headaches. The effectiveness of the Enermed Therapy has been evaluated through controlled clinical trials. Additionally a company survey mailed to Enermed patients one to fifteen months after they received their individually programmed Enermed devices indicated that the large majority of people using the device experienced improvement in their condition.
At this time the Company is also pleased to announce that that the two founding principals of Energy Medicine Developments doing business as ENERMED have agreed to join its Board of Directors. After incorporating Energy Medicine Developments in 1994 the principals have overseen the opening of the initial treatment centre in Vancouver, British Columbia in 1995 and a second treatment centre in Toronto, Ontario in 1997. Both have been active in the Company's growth and will continue to oversee the ongoing growth of the business in North America and internationally.
Robert Michael Fletcher, CGA; educated in Great Britain, he worked in England and on contract in Bermuda, before he emigrated to Canada in 1972. He was employed as Senior Vice President Canada by a US based, multi national financial organization which was responsible for providing corporate finance and consulting advice. He incorporated his own specialized corporate financial service company in 1983. He became a consultant to the health care industry in the early 1990's and together with Fraser Wilson Lawrie was responsible for the incorporation of Energy Medicine Developments in 1994. He has been actively involved with the Company since its incorporation. He received his Certified General Accountant designation in 1985.
Fraser Wilson Lawrie, M.S.; educated in Scotland, he emigrated to Canada in 1979 and pursued a career in the pharmaceutical industry. Whilst working as a consultant to the health care industry he became interested in pulsed electromagnetic therapy in the early 1990's culminating in the establishment of Energy Medicine Developments in 1994. He has been actively involved with the Company since its incorporation. He has a Masters Degree in Health Science.
The Company is also pleased to confirm Energy Medicine Developments Medical Advisory Board chaired by Dr. Martha Lappin and including Robert Fabiny, MD, Ph.D.; Eric Kramer, MD; and Todd Richards, Ph.D. as announced December 4th, 2001.
For more information on the Enermed Therapy for the symptomatic relief of MS and Migraine headaches visit the Company's website at www.enermed.com (http://www.enermed.com) or, to schedule an appointment for the Enermed Therapy call 1-866-ENERMED. For information on Investor Relations, contact Yorkville Capital Partners, LLC at (212) 585-2300.
Certain of these statements contained in the press release may be deemed forward-looking statements. Such statements, and other matters addressed in this press release, involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from these statements and matters are the risks and other factors detailed, from time to time, in the Company's reports with Securities and Exchange Commissions, including, but not limited to, the Company's Annual Reports on Form 10-K and its Quarterly Reports on Form 10-Q.